|20th October 2020||Joana Goncalves||2,000||Open or private sale||$15.00||$30,000.00|
|3rd September 2020||Derek T Chalmers||3,201||Open or private sale||$16.00||$51,216.00|
|3rd August 2020||Derek T Chalmers||5,000||Open or private sale||$16.42||$82,100.00|
|1st July 2020||Derek T Chalmers||5,000||Open or private sale||$17.11||$85,550.00|
|12th June 2020||Joana Goncalves||10,627||Open or private sale||$15.20||$161,530.40|
|10th June 2020||Joana Goncalves||30,000||Grant/award etc.||$0.00|
|4th June 2020||Harrison M Jr Bains||7,200||Grant/award etc.||$0.00|
|4th June 2020||Jeffrey L. Ives||7,200||Grant/award etc.||$0.00|
|4th June 2020||Christopher Posner||7,200||Grant/award etc.||$0.00|
|4th June 2020||Martin Vogelbaum||14,400||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frédérique Menzaghi on July 2, 2004.